Search

Your search keyword '"Ipilimumab -- Forecasts and trends"' showing total 11 results
Start Over Descriptor "Ipilimumab -- Forecasts and trends" Journal globenewswire
11 results on '"Ipilimumab -- Forecasts and trends"'

1. BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D Day

Subjects
Ipilimumab -- Forecasts and trends, Lung cancer, Non-small cell -- Care and treatment, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Clinical benefit observed among non-small cell lung cancer (NSCLC) patients harboring mutant KRAS (mKRAS) variants in the Phase 2 mecbotamab vedotin (CAB-AXL-ADC) study; AXL tumoral expression highly associated with multiple [...]

Published
2024

2. BioAtla to Host Virtual R&D Day to Review BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types on Wednesday, December 13, 2023

Subjects
Tumors -- Forecasts and trends, Ipilimumab -- Forecasts and trends, Vemurafenib -- Forecasts and trends, Immunotherapy -- Forecasts and trends, Melanoma -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the [...]

Published
2023

3. Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma

Subjects
Medical research -- Forecasts and trends, Medicine, Experimental -- Forecasts and trends, Biopharmaceutics -- Forecasts and trends, Ipilimumab -- Forecasts and trends, Metastasis -- Drug therapy, Immunotherapy -- Forecasts and trends, Melanoma -- Drug therapy, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal sodium) [...]

Published
2023

4. Lung Cancer Treatment Market Revenue to Cross USD 102 billion by 2031, Expanding at a CAGR of 9.8% Says, Transparency Market Research Inc

Subjects
Ipilimumab -- Forecasts and trends, Respiratory agents -- Forecasts and trends, Cancer -- Care and treatment, Lung cancer -- Forecasts and trends, Marketing research, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Wilmington, Delaware, United States, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global lung cancer treatment market is projected to flourish at a CAGR of 9.8% [...]

Published
2023

5. Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update

Subjects
Sanofi S.A. -- Forecasts and trends -- Company sales and earnings, Ipilimumab -- Forecasts and trends, Liver cancer -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends -- Company sales and earnings, Market trend/market analysis, Company earnings/profit, Banking, finance and accounting industries, Business
Abstract

- Clinical data for wholly-owned anti-CTLA-4 franchise show best-in-class safety profiles for unmasked and masked candidates, unlocking the full therapeutic benefit of anti-CTLA-4 in combination with anti-PD-1 and beyond - [...]

Published
2023

6. Immune Checkpoint Inhibitors Global Market Report 2022: Featuring Bristol-Myers Squibb, Merck, Novartis, Pfizer & More

Subjects
Ipilimumab -- Forecasts and trends, Immunotherapy -- Forecasts and trends, Monoclonal antibodies -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The https://www.researchandmarkets.com/reports/5669031/immune-checkpoint-inhibitors-market-by-drug?utm_source=GNOM&utm_medium=PressRelease&utm_code=nnc79v&utm_campaign=1784678+-+Immune+Checkpoint+Inhibitors+Global+Market+Report+2022%3a+Featuring+Bristol-Myers+Squibb%2c+Merck%2c+Novartis%2c+Pfizer+%26+More&utm_exec=como322prd report has been added to ResearchAndMarkets.com's offering. Immune checkpoint inhibitors are a part of immuno-oncology therapies, which involves use of patients' [...]

Published
2022

7. Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

Subjects
Ipilimumab -- Forecasts and trends, Cancer -- Care and treatment -- Forecasts and trends, Monoclonal antibodies -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, Oct 11, 2021 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031' - https://www.reportlinker.com/p06135078/?utm_source=GNW The Checkpoint Inhibitors [...]

Published
2021

8. Provectus Biopharmaceuticals Receives Notice of Allowance for Adult Solid Tumor Cancer Combination Therapy Patent for PV-10(R) Immunotherapy from United States Patent and Trademark Office

Subjects
Biopharmaceutics -- Forecasts and trends -- Intellectual property, Prostate cancer -- Development and progression, Trademarks -- Forecasts and trends, Ipilimumab -- Forecasts and trends, Immunotherapy -- Forecasts and trends, Cancer -- Care and treatment, Lung cancer, Non-small cell -- Development and progression, Liver cancer -- Development and progression, Melanoma -- Development and progression, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

KNOXVILLE, TN, Mar 30, 2021 (GLOBE NEWSWIRE via COMTEX) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent (USP) application [...]

Published
2021

9. Immunotherapy Drugs: Global Markets Through 2019, 2020, and 2021-2025

Subjects
Interferon -- Forecasts and trends, Ipilimumab -- Forecasts and trends, Biological products -- Forecasts and trends, Immunotherapy -- Forecasts and trends, Monoclonal antibodies -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, March 29, Mar 29, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Immunotherapy Drugs: Global Markets' report has been added to ResearchAndMarkets.com's offering. The global immunotherapy market can be segmented [...]

Published
2021

10. Global Immunocytokines Market Report 2021-2030: Current and Future Potential of Immunocytokines Being Developed for the Treatment of Rheumatoid Arthritis and Various Types of Cancer

Subjects
Rheumatoid factor -- Forecasts and trends, Ipilimumab -- Forecasts and trends, Arthritis -- Forecasts and trends, Cancer -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, March 25, Mar 25, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Immunocytokines Market by Indication, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030' report [...]

Published
2021

11. Provectus Biopharmaceuticals Announces Oral Presentation of Updated Data from Combination Therapy Trial of PV-10(R) and Keytruda(R) for Checkpoint-Refractory Advanced Cutaneous Melanoma at Melanoma Bridge 2020

Subjects
Biopharmaceutics -- Forecasts and trends, Ipilimumab -- Forecasts and trends, Immunotherapy -- Forecasts and trends, Clinical trials -- Forecasts and trends, Melanoma -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business, Keytruda (Medication)
Abstract

KNOXVILLE, TN, Dec 07, 2020 (GLOBE NEWSWIRE via COMTEX) -- -- 29% ORR (7% CR) and 57% DCR (RECIST 1.1) -- 75% ORR in anti-PD-1-refractory patients -- 56% DCR (11% [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results